What if a drug could stimulate your body’s own cells to mend a stubborn fracture that refuses to heal and leaves you with poor function and debilitating pain? That’s exactly what a group of Orthopedic specialists at Univ of Rochester noticed in their patients on a next generation of osteoporosis drug called Forteo. Fosomax, Boniva, Actonel, Reclast all work by slowing bone loss. Forteo, acts by stimulating the cells that create new bone. Still the expense and potential side effects of this new drug will keep it on the back burner as a 3rd line treatment. But for a select group of patients, this medication may hold promise for both osteoporosis refractory to standard treatment and for fractures that just won’t heal.
Today we will speak with Dr Susan Bukata, Director and Associate Professor for the Center for Bone health at the University of Rochester Medical Center and board certified orthopedic surgeon.
written by Dr Jim \\ tags: actonel, bisphosphonates, bone health, boniva, compression fracture, Dr Susan Bukata, Forteo, fosomax, non-union fractures, osteoporosis, reclast, Rochester University Medical Center, stress fractures
